P01.005 The impact of thrombocytopenia from concomitant and adjuvant temozolomide in patients with glioblastoma

BACKGROUND: Temozolomide (TMZ) administered daily with radiation therapy for six weeks, followed by adjuvant TMZ for six months is standard therapy for patients (pts) with newly diagnosed glioblastoma (GBM). Thrombocytopenia (TBP) usually appears in 10 % of patients and is responsible for treatment...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Nivet, A, Schernberg, A, Louvel, G, Dumont, S, Ammary, S, Rehalia-Blanchard, A, Clavère, P, Parker, F, Pallud, J, Dhermain, F
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Poster Presentations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144430/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.047
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados